Kalaris sets Aug 12, 2025 annual meeting; stockholder proposals due June 30

Kalaris Therapeutics, Inc.

2025 annual meeting scheduled for August 12, 2025; postponed from typical anniversary date.
Rule 14a-8 stockholder proposals must be received by June 30, 2025 to be included in proxy materials.
Director nominations under by-laws also due June 30, 2025, as meeting delayed over 60 days from prior year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.